Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P240001/S001

PearlMatrix P-15 Peptide Enhanced Bone Graft (PearlMatrix Bone Graft)

Cerapedics, Inc. · Decision date Dec 11, 2025

FDA DECISIONP240001/S001

What did the FDA approve?

FDA records P240001/S001 as a supplement to PMA P240001, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Dec 11, 2025.

FDA approval order statement

Approval to allow implantation of the product using additional open or minimally invasive surgical approaches: ALIF (anterior lumbar interbody fusion), TLIF (transforaminal lumbar interbody fusion), PLIF (posterior lumbar interbody fusion), OLIF/ATP (oblique lumbar interbody fusion/anterior to psoas) and LLIF (lateral lumbar interbody fusion); and approval to allow use of the product with titanium alloy and PEEK/titanium interbody fusion cages, as well as the original PEEK interbody fusion cages.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Orthopedic
Decision date
Dec 11, 2025
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P240001/S001
Regulatory pathway
PMA supplement
Product code
NOX
Decision code
APPR
Decision date
Dec 11, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Filler, bone void, synthetic peptide.

Product code
NOX
FDA device class
3

For the original device and its historical approval scope, see PMA P240001. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P240001 · Original PMA

    PearlMatrix Bone Graft

  2. P240001/S001 received

    Application receipt date recorded by FDA.

  3. P240001/S001 · FDA decision

    Normal 180 Day Track

  4. P240001/S002 · Related supplement

    PearlMatrix Peptide Enhanced Bone Graft

  5. P240001/S003 · Related supplement

    PearlMatrixTM Peptide Enhanced Bone Graft

Timeline entries are records held by MedtechLedger for P240001. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240001

Product / regulatory recordCompanyPathwayDecision dateSource
Cerapedics, Inc.PMA approvalJun 18, 2025FDA
Cerapedics, Inc.PMA supplementApr 7, 2026FDA
Cerapedics, Inc.PMA supplementSep 16, 2026FDA

Explore the linked device profile

Other records with product code NOX

Product / regulatory recordCompanyPathwayDecision dateSource
Cerapedics, LLCPMA supplementSep 16, 2026FDA
Cerapedics, LLCPMA supplementApr 7, 2026FDA
Cerapedics, LLCPMA approvalNov 3, 2015FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cerapedics, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
11025 Dover St., Suite 1600, Westminster, CO, 80021

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records